Articles

Fed effort to restore price sanity suffers setbacks.

President Donald Trump unveiled a plan Thursday to implement new reciprocal tariffs on U.S. trading partners.

Credit-card bills and car loans swelled at the end of 2024.

West Pharmaceutical Services Inc.’s stock tumbled 33% Thursday, to lead S&P 500 decliners, after the manufacturer of injectable-pharmaceutical packaging and delivery systems offered guidance for 2025 that was well below expectations.

The continued momentum for Intel’s stock could force hedge funds to start buying. Plus, Intel’s process technology is getting more respect.

Nvidia investors could be disappointed by trends in the current quarter, but there’s big opportunity beyond that point for the company’s new chips.

Mortgage rates fell for the fourth week in a row, offering a glimmer of hope to home buyers.

A Leerink analyst says CVS is starting to benefit from stabilization in its Aetna health-insurance and pharmacy-benefits businesses.

Here’s why the U.S. stock market might not mind higher for longer interest rates.

Data show that more chips were shipped to PC makers in the fourth quarter than demand currently merits.

Everyone loves the tax-free benefits of Roth accounts for growth, but investments don’t always go up.

Private credit has become an increasingly popular asset class, with investments from insurance carriers and pension funds to drive returns.